These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 30739550)
21. Juvenile Animal Testing: Assessing Need and Use in the Drug Product Label. Baldrick P Ther Innov Regul Sci; 2018 Sep; 52(5):641-648. PubMed ID: 29714556 [TBL] [Abstract][Full Text] [Related]
22. Points to Consider in Designing and Conducting Juvenile Toxicology Studies. Kim NN; Parker RM; Weinbauer GF; Remick AK; Steinbach T Int J Toxicol; 2017; 36(4):325-339. PubMed ID: 28466670 [TBL] [Abstract][Full Text] [Related]
23. A functional observational battery for use in canine toxicity studies: development and validation. Gad SC; Gad SE Int J Toxicol; 2003; 22(6):415-22. PubMed ID: 14680988 [TBL] [Abstract][Full Text] [Related]
24. Juvenile Nonclinical Safety Studies in Support of Pediatric Drug Development. Barrow PC; Schmitt G Methods Mol Biol; 2017; 1641():25-67. PubMed ID: 28748457 [TBL] [Abstract][Full Text] [Related]
26. Implementation of a primary screen for developmental neurotoxicity. Wier PJ; Guerriero FJ; Walker RF Fundam Appl Toxicol; 1989 Jul; 13(1):118-36. PubMed ID: 2767352 [TBL] [Abstract][Full Text] [Related]
27. Use of anesthetic agents in neonates and young children. Mellon RD; Simone AF; Rappaport BA Anesth Analg; 2007 Mar; 104(3):509-20. PubMed ID: 17312200 [TBL] [Abstract][Full Text] [Related]
28. Juvenile animal studies for the development of paediatric medicines: a description and conclusions from a European Medicines Agency workshop on juvenile animal testing for nonclinical assessors. Silva-Lima B; Due Theilade-Thomsen M; Carleer J; Vidal JM; Tomasi P; Saint-Raymond A Birth Defects Res B Dev Reprod Toxicol; 2010 Dec; 89(6):467-73. PubMed ID: 20632393 [TBL] [Abstract][Full Text] [Related]
29. Preclinical safety evaluations supporting pediatric drug development with biopharmaceuticals: strategy, challenges, current practices. Morford LL; Bowman CJ; Blanset DL; Bøgh IB; Chellman GJ; Halpern WG; Weinbauer GF; Coogan TP Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):359-80. PubMed ID: 21770023 [TBL] [Abstract][Full Text] [Related]
30. An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugs. Leighton JK; Saber H; Reaman G; Pazdur R Regul Toxicol Pharmacol; 2016 Aug; 79():142-143. PubMed ID: 26952647 [No Abstract] [Full Text] [Related]
31. The value of juvenile animal studies: a Japanese industry perspective. Shimomura K Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):266-8. PubMed ID: 21594974 [TBL] [Abstract][Full Text] [Related]
32. Regulatory Perspectives on Juvenile Animal Toxicologic Pathology. Rao DB; Hoberman AM; Brown PC; Varela A; Bolon B Toxicol Pathol; 2021 Dec; 49(8):1393-1404. PubMed ID: 34620014 [TBL] [Abstract][Full Text] [Related]
33. Relative equivalence of CNS safety (FOB) assessment outcomes in male and female Wistar-Han and Sprague-Dawley rats. Gauvin DV; Dalton JA; Harter ML; Holdsworth D; May J; Tapp R; Zimmermann ZJ; Kilgus Q; Baird TJ J Pharmacol Toxicol Methods; 2019; 95():2-11. PubMed ID: 30476622 [TBL] [Abstract][Full Text] [Related]
34. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act. Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462 [TBL] [Abstract][Full Text] [Related]
35. A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures. Vorhees CV; Sprowles JN; Regan SL; Williams MT Toxicol Appl Pharmacol; 2018 Sep; 354():176-190. PubMed ID: 29544898 [TBL] [Abstract][Full Text] [Related]
36. NTP technical report on the toxicity studies of a Chemical Mixture of 25 Groundwater Contaminants Administered in Drinking Water to F344/N Rats and B6C3F(1) Mice. Yang R Toxic Rep Ser; 1993 Aug; 35():1-I12. PubMed ID: 12209189 [TBL] [Abstract][Full Text] [Related]
37. The use of developmental neurotoxicity data in pesticide risk assessments. Raffaele KC; Rowland J; May B; Makris SL; Schumacher K; Scarano LJ Neurotoxicol Teratol; 2010; 32(5):563-72. PubMed ID: 20398750 [TBL] [Abstract][Full Text] [Related]
38. International Regulatory Guiding Documents and Best Practice Recommendations on Peripheral Nervous System (PNS) Histopathologic Evaluation in Good Laboratory Practice (GLP)-Compliant Animal Toxicity Studies. Bolon B; Bradley A; Butt MT; Jensen K; Rao DB Toxicol Pathol; 2020 Jan; 48(1):78-86. PubMed ID: 31345129 [TBL] [Abstract][Full Text] [Related]
39. Comparative juvenile safety testing of new therapeutic candidates: relevance of laboratory animal data to children. Anderson T; Khan NK; Tassinari MS; Hurtt ME J Toxicol Sci; 2009; 34 Suppl 2():SP209-15. PubMed ID: 19571471 [TBL] [Abstract][Full Text] [Related]
40. Toxicologic Pathology Forum: Current Status on the Use of Animal Models of Human Disease in the Pharmaceutical Industry in Japan in Nonclinical Safety Assessment-Opinion Paper. Tomohiro M; Okabe T; Kimura Y; Kinoshita K; Maeda M; Mitobe Y; Motoyama K; Yonezawa R; Sasaki S; Fujiwara M; Watanabe K Toxicol Pathol; 2019 Feb; 47(2):108-120. PubMed ID: 30636562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]